Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.

Wang, Shih-Chung

Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia. [electronic resource] - Pediatric blood & cancer 02 2020 - e28075 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1545-5017

10.1002/pbc.28075 doi


Adolescent
Case-Control Studies
Child
Child, Preschool
Cytokines--metabolism
Female
Follow-Up Studies
Humans
Immunity, Innate--drug effects
Immunoglobulins, Intravenous--administration & dosage
Lymphocytes--drug effects
Male
Prognosis
Prospective Studies
Purpura, Thrombocytopenic, Idiopathic--drug therapy
T-Lymphocytes, Regulatory--drug effects